Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyery Kim

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Plos One|October 3, 2012
Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphismHyery Kim, Hyoung Jin Kang, Hyo Jeong Kim, et al.
Plos One|June 6, 2013
Pharmacogenetic study of deferasirox, an iron chelating agentJi Won Lee, Hyoung Jin Kang, Ji-Yeob Choi, et al.
Korean Journal of Pediatrics|October 30, 2015
Hemophagocytic lymphohistiocytosis diagnosed by brain biopsyHee Young Ju, Che Ry Hong, Sung Jin Kim, et al.
Korean Journal of Pediatrics|December 27, 2016
Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous diseaseHee Young Ju, Hyoung Jin Kang, Che Ry Hong, et al.
Scientific Reports|May 7, 2021
Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMTHyery Kim, Seungwon You, Yoomi Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modelingJi Won Lee, Hyoung Jin Kang, Seung Hwan Lee, et al.
Therapeutic Drug Monitoring|December 4, 2018
Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic LeukemiaSoo Young Moon, Ji-Hyun Lim, Eun-Hee Kim, et al.
Clinical Drug Investigation|May 30, 2015
Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic stem cell transplantationHyery Kim, Donghoon Shin, Hyoung Jin Kang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 26, 2014
Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patientsJi Won Lee, Hyoung Jin Kang, Sungjin Kim, et al.
Drug Design, Development and Therapy|January 1, 2016
Association of systolic blood pressure drop with intravenous administration of itraconazole in children with hemato-oncologic diseaseHyeong Jin Lee, Bongjin Lee, June Dong Park, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Plos One|October 3, 2012
Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphismHyery Kim, Hyoung Jin Kang, Hyo Jeong Kim, et al.
Plos One|June 6, 2013
Pharmacogenetic study of deferasirox, an iron chelating agentJi Won Lee, Hyoung Jin Kang, Ji-Yeob Choi, et al.
Korean Journal of Pediatrics|October 30, 2015
Hemophagocytic lymphohistiocytosis diagnosed by brain biopsyHee Young Ju, Che Ry Hong, Sung Jin Kim, et al.
Korean Journal of Pediatrics|December 27, 2016
Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous diseaseHee Young Ju, Hyoung Jin Kang, Che Ry Hong, et al.
Scientific Reports|May 7, 2021
Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMTHyery Kim, Seungwon You, Yoomi Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modelingJi Won Lee, Hyoung Jin Kang, Seung Hwan Lee, et al.
Therapeutic Drug Monitoring|December 4, 2018
Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic LeukemiaSoo Young Moon, Ji-Hyun Lim, Eun-Hee Kim, et al.
Clinical Drug Investigation|May 30, 2015
Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic stem cell transplantationHyery Kim, Donghoon Shin, Hyoung Jin Kang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 26, 2014
Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patientsJi Won Lee, Hyoung Jin Kang, Sungjin Kim, et al.
Drug Design, Development and Therapy|January 1, 2016
Association of systolic blood pressure drop with intravenous administration of itraconazole in children with hemato-oncologic diseaseHyeong Jin Lee, Bongjin Lee, June Dong Park, et al.
Pageof 11